Page last updated: 2024-08-26

3,4-dihydroxyphenylglycol and Syndrome

3,4-dihydroxyphenylglycol has been researched along with Syndrome in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cannon, RO; Dendi, R; Eisenhofer, G; Esler, MD; Frank, SM; Goldstein, DS; Holmes, C; Sharabi, Y	1
Amrein, R; Dingemanse, J; Gieschke, R; Guentert, T; Wallnöfer, A	1

Trials

2 trial(s) available for 3,4-dihydroxyphenylglycol and Syndrome

Article	Year
Cardiac sympathetic dysautonomia in chronic orthostatic intolerance syndromes. Circulation, 2002, Oct-29, Volume: 106, Issue:18 Topics: Adrenergic alpha-2 Receptor Antagonists; Adult; Autonomic Nervous System Diseases; Chronic Disease; Coronary Circulation; Dihydroxyphenylalanine; Dopamine; Female; Heart; Heart Ventricles; Hemodynamics; Humans; Hypotension, Orthostatic; Lower Body Negative Pressure; Male; Methoxyhydroxyphenylglycol; Myocardium; Norepinephrine; Reference Values; Sympathetic Nervous System; Syncope, Vasovagal; Syndrome; Tachycardia; Tomography, Emission-Computed; Yohimbine	2002
Pharmacokinetic and pharmacodynamic interactions between fluoxetine and moclobemide in the investigation of development of the "serotonin syndrome". Clinical pharmacology and therapeutics, 1998, Volume: 63, Issue:4 Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Antidepressive Agents; Benzamides; Blood Platelets; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Moclobemide; Reference Values; Selective Serotonin Reuptake Inhibitors; Syndrome	1998

Article

Year

Cardiac sympathetic dysautonomia in chronic orthostatic intolerance syndromes.

Circulation, 2002, Oct-29, Volume: 106, Issue:18

Topics: Adrenergic alpha-2 Receptor Antagonists; Adult; Autonomic Nervous System Diseases; Chronic Disease; Coronary Circulation; Dihydroxyphenylalanine; Dopamine; Female; Heart; Heart Ventricles; Hemodynamics; Humans; Hypotension, Orthostatic; Lower Body Negative Pressure; Male; Methoxyhydroxyphenylglycol; Myocardium; Norepinephrine; Reference Values; Sympathetic Nervous System; Syncope, Vasovagal; Syndrome; Tachycardia; Tomography, Emission-Computed; Yohimbine

2002

Pharmacokinetic and pharmacodynamic interactions between fluoxetine and moclobemide in the investigation of development of the "serotonin syndrome".

Clinical pharmacology and therapeutics, 1998, Volume: 63, Issue:4

Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Antidepressive Agents; Benzamides; Blood Platelets; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Moclobemide; Reference Values; Selective Serotonin Reuptake Inhibitors; Syndrome

1998